Utilization of Empagliflozin in Patients with Type 2 Diabetes Mellitus and Congestive Heart Failure

被引：0
|
作者：
Alvarez, Carlos A.
Perkins, Aaron
Sigler, Meredith A.
Yang, Hui
Caberwal, Harjeet
Ebrahimi, Ramin
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-872-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
872-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prevalance of Congestive Heart Failure Aniong Patients With Type 2 Diabetes Mellitus
    Ataoglu, Meral
    Karaali, Zeynep
    Poturoglu, Sule
    Aktuglu, Mehmet Burak
    Saglam, Zuhal
    Alioglu, Taner
    Kendir, Mehmet
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2009, 47 (03): : 122 - 128
  • [2] Diabetes mellitus and congestive heart failure: the prevalence of congestive heart failure in patients with and without diabetes in Poland
    Wierzba, Waldemar
    Karnafel, Waldemar
    Sliwczynski, Andrzej
    Pinkas, Jaroslaw
    Gujski, Mariusz
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (03) : 646 - 651
  • [3] Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus
    Filion, Kristian B.
    Joseph, Lawrence
    Boivin, Jean-Francois
    Suissa, Samy
    Brophy, James M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (08) : 785 - 796
  • [4] IMPACT OF EMPAGLIFLOZIN IN REDUCING HOSPITALIZATION RATES IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC HEART FAILURE
    Yagudina, R.
    Kulikov, A.
    Serpik, V
    Protsenko, M.
    Kopeyka, K.
    VALUE IN HEALTH, 2022, 25 (07) : S350 - S350
  • [5] Diabetes Mellitus and Congestive Heart Failure
    Odawara, Masato
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (09) : S139 - S139
  • [6] Heart failure in patients with type 2 diabetes mellitus
    Vlad, Adrian
    Serban, Viorel
    Timar, Romulus
    Darabantiu, Dan
    DIABETES, 2007, 56 : A588 - A588
  • [7] PREDICTORS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH EMPAGLIFLOZIN
    Lebedev, Denis
    Lyasnikova, Elena
    Vasilyeva, Elena
    Sitnikova, Maria
    Babenko, Alina
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E190 - E190
  • [8] PREDICTORS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH EMPAGLIFLOZIN
    Lebedev, Denis
    Lyasnikova, Elena
    Vasilyeva, Elena
    Sitnikova, Maria
    Babenko, Alina
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E190 - E190
  • [9] Mechanistic insights into the effects of empagliflozin in patients with type 2 diabetes and heart failure
    Elrakaybi, A.
    Laubner, K.
    Zhou, Q.
    Paeth, G.
    Schmitt, H.
    Hug, M. J.
    Seufert, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S24 - S24
  • [10] Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure
    Granberry, Mark C.
    Hawkins, Jason B.
    Franks, Amy M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (09) : 931 - 936
12345